CORSO DI CLINICAL COMPETENCE SULLA MALATTIA TOMBROEMBOLICA VENOSA Firenze 4-5 Novembre 2010 DALLA TROMBOSI VENOSA ALL EMBOLIA ALL IPERTENSIONE POLMONARE.
THROMBOPHILIA ANDCORONARY ARTERY DISEASE Giovanni Barillari ANCO FVG Palmanova 17 ottobre 2009.
Frequency of Monitoring, Non-adherence, and Other Anticoagulation Topics Nathan Clark, Pharm D, BCPS Clinical Pharmacy Supervisor Anticoagulation and Anemia.
Pgs.TS. NguyÔn Quang TuÊn, FACC, fscai ViÖn tim m¹ch ViÖt nam TĂNG HUYT ÁP VÀ BNH ĐNG MCH VÀNH TĂNG HUYT ÁP VÀ BNH ĐNG MCH VÀNH.
MEND-CABG II ACC08 LBCT JHA, 1 John H. Alexander, MD, MS, FACC Robert W. Emery, MD, FACC On behalf of the MEND-CABG II Investigators A Randomized, Double-blind,
Body and Mind: Metabolic Syndrome and Mental Health A workshop to discuss the management of metabolic issues in people with mental illness.
Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano 9 - 10 aprile 2010 ICD data.
Asymptomatic Left Ventricular Dysfunction After Myocardial Infarction Nancy M. Albert PhD, CCNS, CCRN, NE-BC, FAHA, FCCM Nursing Research & Kaufman Center.
MEND-CABG II ACC08 LBCT JHA, 1 John H. Alexander, MD, MS, FACC On behalf of the MEND-CABG II Investigators A Randomized, Double-blind, Placebo-controlled,
Medical Treatment Options for Obesity Jennifer DeBruler, M.D. Medical Director Advocate Weight Management Board Certified Internal Medicine October 2012.
Cardiopatia ischemica: nuovi orizzonti nella terapia con antiaggreganti orali Giancarlo Casolo Genova, Hotel NH Marina 21/22 Ottobre 2011 HEARTLINE HSM.
Achieving Good Glycemic Control. Aim Provide practical guidance on improving diabetes care through highlighting the need to: treat to glucose targets.